KEGG   DRUG: Pertuzumab, trastuzumab and hyaluronidase
Entry
D11934            Mixture   Drug                                   

Name
Pertuzumab, trastuzumab and hyaluronidase;
Pertuzumab, trastuzumab and hyaluronidase-zzxf;
Phesgo (TN)
Product
Component
Pertuzumab [DR:D05446], Trastuzumab [DR:D03257], Hyaluronidase [DR:D04456]
Remark
ATC code: L01XY02
Product: D11934<US>
Efficacy
Antineoplastic
  Disease
Breast cancer [DS:H00031]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XY Combinations of antineoplastic agents
     L01XY02 Pertuzumab and trastuzumab
      D11934  Pertuzumab, trastuzumab and hyaluronidase <US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11934
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system